The Cross-talk between Tristetraprolin and Cytokines in Cancer

Jian Guo1, Hao Wang1, Shiyi Jiang1

  • 1Department of General Surgery and Translational Medicine Center, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi, 214002, China.

Insights

Tristetraprolin (TTP) negatively regulates inflammatory and oncogenic cytokines by binding to mRNA. This cross-regulation between cytokines and TTP impacts cancer development, highlighting complex networks in tumorigenesis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Cytokines are key mediators of immune responses, with their expression tightly regulated at transcriptional and post-transcriptional levels.
  • AU-rich elements (AREs) in mRNA are crucial for regulating translation and decay, often interacting with specific binding proteins.
  • Tristetraprolin (TTP) is a primary ARE-binding protein known to negatively control cytokine expression.

Purpose of the Study:

  • To review the regulatory mechanisms of cytokine messenger RNA (mRNA).
  • To elucidate the role of TTP in negatively regulating inflammatory and oncogenic cytokines via ARE binding.
  • To examine the reciprocal regulation between cytokines and TTP in various cancers.

Main Methods:

  • Literature review focusing on cytokine mRNA regulation.
  • Analysis of TTP's interaction with AREs in the 3'-untranslated region (3'UTR) of cytokine mRNAs.
  • Investigation of cytokine-mediated effects on TTP expression and function.

Main Results:

  • TTP binds to AREs in cytokine mRNA, leading to decreased translation and increased decay.
  • Certain cytokines influence TTP expression and activity, creating a feedback loop.
  • The interplay between TTP and cytokines is implicated in the complex regulatory networks governing tumorigenesis.

Conclusions:

  • TTP acts as a critical negative regulator of pro-tumorigenic and inflammatory cytokines.
  • The cross-talk between cytokines and TTP is a significant factor in cancer development and progression.
  • Understanding these intricate regulatory networks is vital for cancer research and therapeutic strategies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...